IRWD Ironwood Pharmaceuticals PE ratio, current and historical analysis
As at Apr 2, 2025, the IRWD stock has a PE ratio of 144.0. This is based on the current EPS of $0.01 and the stock price of $1.44 per share.
IRWD PE ratio history
The mean historical PE ratio of Ironwood Pharmaceuticals over the last six years is 48.74. The current 144.0 PE ratio is 195% above the historical average. Over the past six years, IRWD's PE ratio was at its highest in the Dec 2024 quarter at 443, with a price of $4.43 and an EPS of $0.01. The Dec 2021 quarter recorded the bottom point at 3.58, with a price of $11.66 and an EPS of $3.26.
Ironwood Pharmaceuticals PE ratio by year
Maximum annual increase: 206.15% in 2022
Maximum annual decrease: -82.12% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 443 | N/A | $4.43 | $0.01 |
| 2023 | N/A | N/A | $11.44 | -$6.45 |
| 2022 | 10.96 | 206.15% | $12.39 | $1.13 |
| 2021 | 3.58 | -78.94% | $11.66 | $3.26 |
| 2020 | 17 | -82.12% | $11.39 | $0.67 |
| 2019 | 95.07 | N/A | $13.31 | $0.14 |
| 2018 | N/A | N/A | $10.36 | -$1.85 |
| 2017 | N/A | N/A | $14.99 | -$0.78 |
| 2016 | N/A | N/A | $15.29 | -$0.56 |
| 2015 | N/A | N/A | $11.59 | -$1 |
| 2014 | N/A | N/A | $15.32 | -$1.39 |
| 2013 | N/A | N/A | $11.61 | -$2.35 |
| 2012 | N/A | N/A | $11.08 | -$0.68 |
| 2011 | N/A | N/A | $11.97 | -$0.65 |
| 2010 | N/A | N/A | $10.35 | -$0.59 |
Ironwood Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 443 | N/A | $4.43 | $0.01 |
| Sep 2024 | N/A | N/A | $4.12 | -$0.02 |
| Jun 2024 | 108.67 | N/A | $6.52 | $0.06 |
| Mar 2024 | N/A | N/A | $8.71 | -$6.77 |
| Dec 2023 | N/A | N/A | $11.44 | -$6.45 |
| Sep 2023 | N/A | N/A | $9.63 | -$6.13 |
| Jun 2023 | N/A | N/A | $10.64 | -$5.9 |
| Mar 2023 | 8.92 | -18.61% | $10.52 | $1.18 |
| Dec 2022 | 10.96 | 13.22% | $12.39 | $1.13 |
| Sep 2022 | 9.68 | -9.36% | $10.36 | $1.07 |
| Jun 2022 | 10.68 | 176.68% | $11.53 | $1.08 |
| Mar 2022 | 3.86 | 7.82% | $12.58 | $3.26 |
| Dec 2021 | 3.58 | -10.05% | $11.66 | $3.26 |
| Sep 2021 | 3.98 | -2.21% | $13.06 | $3.28 |
| Jun 2021 | 4.07 | -67.23% | $12.87 | $3.16 |
IRWD average PE ratio chart
The current PE ratio of IRWD is greater than its 3, 5 and 10-year historical averages.
IRWD PE vs peers
IRWD's PE ratio is higher than its peer stock AZN.
| Stock name | PE ratio | Market cap |
|---|---|---|
| AZN Astrazeneca plc | 32.72 | $230.36B |
| IRWD Ironwood Pharmaceuticals Inc | 141.5 | $228.96M |
| CPIX Cumberland Pharmaceuticals Inc | N/A | $60.76M |
| NKTR Nektar Therapeutics | N/A | $109.13M |
Frequently asked questions
What is Ironwood Pharmaceuticals's PE ratio?
As of Apr 2, 2025, IRWD stock has a price to earnings ratio of 144.
What is the 3-year average PE ratio for Ironwood Pharmaceuticals (IRWD)?
Over the last 3 years, the average price to earnings ratio for IRWD stock is 98.65.
What is the 5-year average PE ratio for Ironwood Pharmaceuticals (IRWD)?
Over the last 5 years, the average price to earnings ratio for IRWD stock is 47.58.
What is the highest PE ratio for IRWD?
In the last six years, the Dec 2024 quarter recorded the highest quarterly PE ratio at 443.
How does the current PE ratio for IRWD compare to its historical average?
IRWD's current price to earnings ratio is 195% above its 6-year historical average.
Why is Ironwood Pharmaceuticals's PE ratio so high?
IRWD's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is IRWD's PE ratio calculated (Ironwood Pharmaceuticals PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Apr 2, 2025), Ironwood Pharmaceuticals's stock price is $1.44. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.01. Therefore, Ironwood Pharmaceuticals's P/E ratio for today is 144. PE RATIO(144) = STOCK PRICE($1.44) / TTM EPS($0.01)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.